The FSGS-causing ACTN4 mutation K255E increases podocyte cytoskeleton stiffness [26,27,33]; thus, we hypothesized that it could affect TRPC6 activity. The gene discussed is TRPC6; the disease is focal segmental glomerulosclerosis.